TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $919,119 | +79.7% | 59,413 | +82.4% | 0.00% | +100.0% |
Q2 2023 | $511,580 | -1.2% | 32,564 | +3.6% | 0.00% | 0.0% |
Q1 2023 | $517,884 | -9.1% | 31,425 | -14.0% | 0.00% | -33.3% |
Q4 2022 | $569,884 | +175.3% | 36,531 | +128.9% | 0.00% | +200.0% |
Q3 2022 | $207,000 | +19.0% | 15,958 | +28.6% | 0.00% | 0.0% |
Q2 2022 | $174,000 | +43.8% | 12,405 | +47.1% | 0.00% | 0.0% |
Q1 2022 | $121,000 | -43.2% | 8,434 | -45.9% | 0.00% | 0.0% |
Q4 2021 | $213,000 | +69.0% | 15,601 | +102.1% | 0.00% | 0.0% |
Q3 2021 | $126,000 | -14.9% | 7,720 | -12.3% | 0.00% | 0.0% |
Q2 2021 | $148,000 | 0.0% | 8,804 | +8.6% | 0.00% | -50.0% |
Q1 2021 | $148,000 | +33.3% | 8,107 | +32.4% | 0.00% | +100.0% |
Q4 2020 | $111,000 | +50.0% | 6,122 | +45.6% | 0.00% | 0.0% |
Q3 2020 | $74,000 | +37.0% | 4,204 | +37.7% | 0.00% | 0.0% |
Q2 2020 | $54,000 | – | 3,052 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |